CompanyDeals

HitGen and LoQus23 Therapeutics Partner on DNA Encoded Library for Neurodegeneration

CompanyDeals

Roche Diagnostics and Topgen Biopharm Launch Innovation Center in Chongqing

CompanyDeals

Hybio Pharmaceutical Signs Tech Transfer Deal with China’s CDC for COVID-19 Vaccine Peptide Sequences

CompanyDeals

Yunnan Baiyao and Huawei Partner on AI-Driven Drug Development

CompanyDrug

Sihuan Pharma’s Xuanzhu Bio Files for Fulvestrant-Piroxetine Combo in Advanced Breast Cancer

CompanyDeals

Sichuan Kelun Pharmaceutical and Merck Sharp & Dohme Corp. Ink Second ADC Licensing Deal

CompanyDrug

SinoPharm CNBG’s F61 Monoclonal Antibody Receives NMPA Clinical Trial Approval

CompanyDeals

Legend Biotech Plans USD 250M Secondary Offering to Fund CAR-T Therapy Development

CompanyMedical Device

AbbVie’s Allergan Aesthetics CoolAdvantage Applicator Wins NMPA Approval

CompanyDrug

Henlius Biotech’s Hanquyou Approved in Australia for HER2-Positive Cancers

CompanyDrug

Hengrui Medicine’s SHR-1802 + SHR-1316 Combo Receives NMPA Approval for Solid Tumor Study

CompanyDrug

Betta Pharmaceuticals Enrolls First Patient in BPI-442096 Phase I Study for Solid Tumors